BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3958225)

  • 1. Enhanced bioavailability of triazolam following sublingual versus oral administration.
    Scavone JM; Greenblatt DJ; Friedman H; Shader RI
    J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers.
    Fujii J; Inotsume N; Nakano M
    J Pharmacobiodyn; 1988 Mar; 11(3):206-9. PubMed ID: 3411438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.
    Kroboth PD; McAuley JW; Kroboth FJ; Bertz RJ; Smith RB
    J Clin Psychopharmacol; 1995 Aug; 15(4):259-62. PubMed ID: 7593708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.
    Scavone JM; Luna BG; Harmatz JS; von Moltke L; Greenblatt DJ
    Biopharm Drug Dispos; 1990 Apr; 11(3):185-9. PubMed ID: 2328304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sublingually and orally administered triazolam for premedication before oral surgery.
    Berthold CW; Dionne RA; Corey SE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):119-24. PubMed ID: 9269010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
    Tweedy CM; Milgrom P; Kharasch ED; Kaakko T; Spieker M; Coldwell SE
    J Clin Psychopharmacol; 2001 Jun; 21(3):268-72. PubMed ID: 11386489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral formulations of triazolam using radioreceptor assay.
    Lapka R; Cepeláková H; Rejholec V; Franc Z
    Pharmazie; 1986 Apr; 41(4):256-7. PubMed ID: 3725869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolam kinetics: interaction with cimetidine, propranolol, and the combination.
    Friedman H; Greenblatt DJ; Burstein ES; Scavone JM; Harmatz JS; Shader RI
    J Clin Pharmacol; 1988 Mar; 28(3):228-33. PubMed ID: 3360971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive assay for triazolam in plasma following low oral doses.
    Edeki T; Robin DW; Prakash C; Blair IA; Wood AJ
    J Chromatogr; 1992 May; 577(1):190-4. PubMed ID: 1400742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ranitidine on the disposition of orally and intravenously administered triazolam.
    Vanderveen RP; Jirak JL; Peters GR; Cox SR; Bombardt PA
    Clin Pharm; 1991 Jul; 10(7):539-43. PubMed ID: 1860302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.
    Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI
    Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.
    Hukkinen SK; Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):127-31. PubMed ID: 7648762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic noninteraction of triazolam and ethanol.
    Ochs HR; Greenblatt DJ; Arendt RM; Hübbel W; Shader RI
    J Clin Psychopharmacol; 1984 Apr; 4(2):106-7. PubMed ID: 6142906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
    Lui CY; Amidon GL; Goldberg A
    J Pharm Sci; 1991 Dec; 80(12):1125-9. PubMed ID: 1815070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.